U.S. DoJ will not challenge Aetna-CVS deal: report

(Reuters) – Shares of CVS Health Corp (CVS.N) and health insurer Aetna Inc (AET.
N) rose more than 2 percent on Thursday after CNBC reported that the U.S.
Justice Department will not challenge their planned merger. A CVS Pharmacy store is seen in the Manhattan borough of New York City, New York, U.
S., November 30, 2017.
REUTERS/Shannon StapletonCNBC said Bloomberg reported the news, citing trade publication Reorg Research. CVS Health Corp and Aetna announced the $69 billion deal on Dec.
3 last year, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies. Aetna and CVS declined to comment.
.

 

Related posts

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.